These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 8228533
21. Retinal capillary dilation: early diabetic-like retinopathy in the galactose-fed rat model. Glover JP, Jacot JL, Basso MD, Hohman TC, Robison WG. J Ocul Pharmacol Ther; 2000 Apr; 16(2):167-72. PubMed ID: 10803427 [Abstract] [Full Text] [Related]
22. Polyol formation and NADPH-dependent reductases in dog retinal capillary pericytes and endothelial cells. Sato S, Secchi EF, Lizak MJ, Fukase S, Ohta N, Murata M, Tsai JY, Kador PF. Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):697-704. PubMed ID: 10067973 [Abstract] [Full Text] [Related]
24. Retinal vessel changes in galactose-fed dogs. Kobayashi T, Kubo E, Takahashi Y, Kasahara T, Yonezawa H, Akagi Y. Arch Ophthalmol; 1998 Jun; 116(6):785-9. PubMed ID: 9639449 [Abstract] [Full Text] [Related]
25. Diabeteslike preproliferative retinal changes in galactose-fed dogs. Takahashi Y, Wyman M, Ferris F, Kador PF. Arch Ophthalmol; 1992 Sep; 110(9):1295-302. PubMed ID: 1520120 [Abstract] [Full Text] [Related]
26. Long-term treatment with fidarestat suppresses the development of diabetic retinopathy in STZ-induced diabetic rats. Kato N, Yashima S, Suzuki T, Nakayama Y, Jomori T. J Diabetes Complications; 2003 Sep; 17(6):374-9. PubMed ID: 14583184 [Abstract] [Full Text] [Related]
29. Progression of sugar cataract in the dog. Sato S, Takahashi Y, Wyman M, Kador PF. Invest Ophthalmol Vis Sci; 1991 May; 32(6):1925-31. PubMed ID: 1903366 [Abstract] [Full Text] [Related]
30. Effect of aldose reductase inhibitors on lenticular dulcitol level in galactose fed rats. Unakar NJ, Tsui JY, Johnson MJ. J Ocul Pharmacol; 1992 May; 8(3):199-212. PubMed ID: 1453083 [Abstract] [Full Text] [Related]
31. Aldose reductase inhibitors and prevention of galactose cataracts in rats. Unakar N, Tsui J, Johnson M. Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646 [Abstract] [Full Text] [Related]
32. Diabeteslike proliferative retinal changes in galactose-fed dogs. Kador PF, Takahashi Y, Wyman M, Ferris F. Arch Ophthalmol; 1995 Mar; 113(3):352-4. PubMed ID: 7887849 [Abstract] [Full Text] [Related]
33. Retinal capillary pericyte apoptosis in early human diabetic retinopathy. Li W, Yanoff M, Liu X, Ye X. Chin Med J (Engl); 1997 Sep; 110(9):659-63. PubMed ID: 9642318 [Abstract] [Full Text] [Related]
34. Prefeeding of aldose reductase inhibitor and galactose cataractogenesis. Unakar NJ, Tsui JY, Johnson MJ. Curr Eye Res; 1989 Oct; 8(10):997-1010. PubMed ID: 2558845 [Abstract] [Full Text] [Related]
35. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study. Datiles M, Fukui H, Kuwabara T, Kinoshita JH. Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):174-9. PubMed ID: 6799419 [Abstract] [Full Text] [Related]
36. Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy. Dagher Z, Park YS, Asnaghi V, Hoehn T, Gerhardinger C, Lorenzi M. Diabetes; 2004 Sep; 53(9):2404-11. PubMed ID: 15331552 [Abstract] [Full Text] [Related]
40. Effects of an aldose reductase inhibitor, SNK-860, on the histopathological changes of retinal tissues in a streptozotocin-induced diabetic rat model. Akita M, Mizuno K, Matsubara A, Nakano K, Kurono M. Acta Med Okayama; 1993 Oct; 47(5):299-304. PubMed ID: 8273453 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]